09:31 EDT AbbVie (ABBV) sees net leverage ratio 2x by end of 2026
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ABBV:
- AbbVie sees FY25 revenue ~$60.9B, consensus $60.66B
- AbbVie sees Q4 adjusted EPS $3.32-$3.36, consensus $3.34
- AbbVie says the business continues to perform above expectations
- Morning Movers: Brighthouse Financial surges after take-private deal report
- Options Volatility and Implied Earnings Moves Today, October 31, 2025
